Clinical trial · Interventional
Colorectal Cancer Screening With Improved Shared Decision Making
Colorectal Cancer Screening With Improved Shared Decision Making (CRCS-WISDM)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to increase colorectal cancer screening by implementing a community-wide shared decision-making (SDM) intervention, which embeds shared decision making within clinical practice and also uses an extensive community engagement campaign. The investigators hypothesize that colorectal cancer screening adherence will be higher in the intervention group (participating communities) compared to the usual care control group (non-participating comparison communities).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer Screening | — | UNRESOLVED | — |
| Shared Decision Making | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Shared Decision Making for Colorectal Cancer Screening | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Shared Decision Making
- interventionNames
- Behavioral: Shared Decision Making for Colorectal Cancer Screening
- type
- NO_INTERVENTION
- label
- Comparison (control)
Primary outcomes (1)
- measure
- Change in colorectal cancer screening adherence
- timeFrame
- Baseline up to 24 months post intervention initiation
- description
- Colorectal cancer screening adherence will be defined as having screening according to the recommendations of the United States Preventive Services Task Force. Participants will be classified as screened per recommendations if they have had fecal occult blood testing in the last year, flexible sigmoidoscopy in the last five years, or colonoscopy in the last ten years. Participants will be classified as non-adherent if they have not had any of the modalities within the recommended timeframe.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * 50 to 75 years of age * Lives in or receives care in the selected intervention or comparison (control) communities * Average-risk for colorectal cancer * Non-adherent to CRCS recommendation * English-speaking * People who consent to participate Exclusion Criteria: * \<50 years of age or \>75 years of age * Not living in or receiving care in the selected intervention or comparison communities * High-risk for colorectal cancer * Adherent to CRCS recommendation * Non-English speaking * People who do not consent to participate
References
Publications (0)
Data not yet available